| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer
|
Petrelli, Fausto
|
|
|
9 |
12 |
p. 1079
|
artikel
|
| 2 |
Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer – Authors' reply
|
Sasako, Mitsuro
|
|
|
9 |
12 |
p. 1079-1080
|
artikel
|
| 3 |
A model to achieve microelimination of viral hepatitis in Shabo village, Nasarawa state, Nigeria
|
Shiha, Gamal
|
|
|
9 |
12 |
p. 1082-1084
|
artikel
|
| 4 |
A person-first podcast and the story of Alexis St Martin
|
McQuillan, Cahal
|
|
|
9 |
12 |
p. 1088
|
artikel
|
| 5 |
Availability of point-of-care HBV tests in resource-limited settings
|
Lau, Daryl T Y
|
|
|
9 |
12 |
p. 1073-1076
|
artikel
|
| 6 |
Bowel cancer prevention: are we missing an opportunity?
|
Rees, Colin
|
|
|
9 |
12 |
p. 1080
|
artikel
|
| 7 |
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study
|
Ndow, Gibril
|
|
|
9 |
12 |
p. 1133-1146
|
artikel
|
| 8 |
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
|
Loomba, Rohit
|
|
|
9 |
12 |
p. 1090-1100
|
artikel
|
| 9 |
Dietary management of irritable bowel syndrome: considerations, challenges, and solutions
|
Whelan, Kevin
|
|
|
9 |
12 |
p. 1147-1161
|
artikel
|
| 10 |
Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection?
|
Zoulim, Fabien
|
|
|
9 |
12 |
p. 1069-1071
|
artikel
|
| 11 |
Expanding the armamentarium for metabolic dysfunction-associated steatohepatitis
|
Francque, Sven M
|
|
|
9 |
12 |
p. 1066-1067
|
artikel
|
| 12 |
GLP-1 receptor agonists and bronchial aspiration risk: what the evidence tells us
|
Fuccio, Lorenzo
|
|
|
9 |
12 |
p. 1082
|
artikel
|
| 13 |
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement
|
Lu, Cathy
|
|
|
9 |
12 |
p. 1101-1110
|
artikel
|
| 14 |
Launch of the PANC-PALS Consortium
|
Javed, Ammar A
|
|
|
9 |
12 |
p. 1084-1085
|
artikel
|
| 15 |
Lifting the minority tax in gastroenterology and hepatology
|
Balzora, Sophie M
|
|
|
9 |
12 |
p. 1076-1078
|
artikel
|
| 16 |
Lucky: Learning to Live Again
|
Moody, Joe
|
|
|
9 |
12 |
p. 1089
|
artikel
|
| 17 |
Management of portal vein thrombosis in cirrhosis
|
Violi, Francesco
|
|
|
9 |
12 |
p. 1080-1081
|
artikel
|
| 18 |
Management of portal vein thrombosis in cirrhosis – Authors' reply
|
Rautou, Pierre-Emmanuel
|
|
|
9 |
12 |
p. 1081-1082
|
artikel
|
| 19 |
Pancreaticopleural fistula presenting with a massive right-sided pleural effusion after pancreatitis
|
Shephard, Christopher James
|
|
|
9 |
12 |
p. 1177-1178
|
artikel
|
| 20 |
Personalisation of therapy in irritable bowel syndrome: a hypothesis
|
Black, Christopher J
|
|
|
9 |
12 |
p. 1162-1176
|
artikel
|
| 21 |
Research in Brief
|
Baker, Holly
|
|
|
9 |
12 |
p. 1087
|
artikel
|
| 22 |
Spleen stiffness in portal hypertension algorithms: the next advance
|
Rigamonti, Cristina
|
|
|
9 |
12 |
p. 1067-1069
|
artikel
|
| 23 |
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
|
Jachs, Mathias
|
|
|
9 |
12 |
p. 1111-1120
|
artikel
|
| 24 |
Tackling obesity: drugs are only part of the solution
|
The Lancet Gastroenterology & Hepatology,
|
|
|
9 |
12 |
p. 1065
|
artikel
|
| 25 |
The surety or otherwise of leaving chronic hepatitis B untreated
|
Dusheiko, Geoffrey
|
|
|
9 |
12 |
p. 1071-1073
|
artikel
|
| 26 |
UEG Week 2024
|
Brierley, Rob
|
|
|
9 |
12 |
p. 1086
|
artikel
|
| 27 |
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
|
Yuen, Man-Fung
|
|
|
9 |
12 |
p. 1121-1132
|
artikel
|
Tijdschrift beschrijving